Nexien BioPharma, Inc. (NXEN)
OTCMKTS · Delayed Price · Currency is USD
0.0060
0.00 (0.00%)
Jul 31, 2025, 8:00 PM EDT
Nexien BioPharma Market Cap
Nexien BioPharma has a market cap or net worth of $403.40 thousand as of August 1, 2025. Its market cap has decreased by -80.84% in one year.
Market Cap
403.40K
Enterprise Value
770.49K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 16, 2017, Nexien BioPharma's market cap has decreased from 10.47M to 403.40K, a decrease of -96.15%. That is a compound annual growth rate of -34.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 403.40K | 1.79% |
| Dec 27, 2024 | 396.32K | -76.52% |
| Dec 29, 2023 | 1.69M | -53.72% |
| Dec 29, 2022 | 3.65M | -14.35% |
| Dec 31, 2021 | 4.26M | -14.62% |
| Dec 31, 2020 | 4.99M | 163.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.98M |
| Northwest Biotherapeutics | 351.67M |